Oxidative damage to pre-eclamptic placenta: Immunohistochemical expression of VEGF, nitrotyrosine residues and von Willebrand factor

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 11, 2012, Pages 2339-2345

  Rodrigo, Ramón ^a   Bosco, Cleofina ^a   González, Jaime ^a   Gutiérrez, Rodrigo ^a   Parra Cordero, Mauro ^b   Barja, Pilar ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Oxidative stress; Peroxynitrite; Placenta; Pre eclampsia; VEGF; Von Willebrand factor

Indexed keywords

3 NITROTYROSINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); PEROXYNITRITE; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATERNAL SPACE; MOLECULAR PATHOLOGY; OXIDATIVE STRESS; PLACENTA; PLACENTA PERFUSION; PLACENTAL ENDOTHELIUM; PLACENTAL STROMA; PREECLAMPSIA; PRIMIPARA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESIDUE ANALYSIS; SYNCYTIOTROPHOBLAST; TISSUE DISTRIBUTION;

ADULT; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OXIDATIVE STRESS; PEROXYNITROUS ACID; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TISSUE DISTRIBUTION; TROPHOBLASTS; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 84867497672     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.695823     Document Type: Article

References (64)

1. NHBP. National High Blood-Pressure Education-Program Working Group-Report on High Blood-Pressure in Pregnancy. Am J Obstet Gynecol 1990;163;1691-1712.
2. Redman CW. Current topic: pre-eclampsia and the placenta. Placenta 1991;12:301-308.
3. Scott JS. Pregnancy toxaemia associated with hydrops foetalis, hydatidiform mole and hydramnios. J Obstet Gynaecol Br Emp 1958;65:689-701.
4. Hou JL, Wan XR, Xiang Y, Qi Q W, Yang XY. Changes of clinical features in hydatidiform mole: analysis of 113 cases. J Reprod Med 2008;53:629-633.
5. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-898.
6. Aquilina J, Harrington K. Pregnancy hypertension and uterine artery Doppler ultrasound. Curr Opin Obstet Gynecol 1996;8:435-440. (Pubitemid 26424340)
7. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004;11:342-352. (Pubitemid 39185874)
8. Merviel P, Carbillon L, Challier JC, Rabreau M, Beaufils M, Uzan S. Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol 2004;115:134-147. (Pubitemid 38953029)
9. Myatt L. Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010;31 Suppl:S66-S69.
10. Li ZH, Zlabek V, Grabic R, Li P, Machova J, Velisek J, Randak T. Effects of exposure to sublethal propiconazole on the antioxidant defense system and Na+-K+-ATPase activity in brain of rainbow trout, Oncorhynchus mykiss. Aquat Toxicol 2010;98:297-303.
11. Elliott SJ, Koliwad SK. Oxidant stress and endothelial membrane transport. Free Radic Biol Med 1995;19:649-658.
12. Graves S W. Sodium regulation, sodium pump function and sodium pump inhibitors in uncomplicated pregnancy and preeclampsia. Front Biosci 2007;12:2438-2446.
13. Dötsch J, Hogen N, Nyúl Z, Hänze J, Knerr I, Kirschbaum M, Rascher W. Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation. Eur J Obstet Gynecol Reprod Biol 2001;97:163-167. (Pubitemid 32645650)
14. Var A, Yildirim Y, Onur E, Kuscu NK, Uyanik BS, Goktalay K, Guvenc Y. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 2003;56:221-224. (Pubitemid 37505854)
15. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
16. Lyall F, Young A, Boswell F, Kingdom JC, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997;18:269-276. (Pubitemid 27214230)
17. Oh MJ, Lee JK, Lee NW, Shin JH, Yeo MK, Kim A, Kim IS, Kim HJ. Vascular endothelial growth factor expression is unaltered in placentae and myometrial resistance arteries from pre-eclamptic patients. Acta Obstet Gynecol Scand 2006;85:545-550. (Pubitemid 43995069)
18. Sgambati E, Marini M, Zappoli Thyrion GD, Parretti E, Mello G, Orlando C, Simi L, et al. VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 2004;111:564-570. (Pubitemid 38746240)
19. Bosco C, Buffet C, Díaz E, Rodrigo R, Morales P, Barja P, Terra R, Parra-Cordero M. VEGF in the muscular layer of placental blood vessels: immuno-expression in preeclampsia and intrauterine growth restriction and its association with the antioxidant status. Cardiovasc Hematol Agents Med Chem 2010;8:87-95.
20. Kroll J, Waltenberger J. VEGF - A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 1998;252:743-746. (Pubitemid 28556847)
21. Dulak J, Józkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, Florek I, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:659-666. (Pubitemid 30151678)
22. Tranquilli AL, Bezzeccheri V, Giannubilo SR, Scagnoli C, Mazzanti L, Garzetti GG. Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004;113:17-20. (Pubitemid 38281188)
23. Dittman WA, Majerus P W. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990;75:329-336. (Pubitemid 20035260)
24. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982;95:355-360. (Pubitemid 13208536)
25. van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 2002;117:113-122.
26. Bergmann F, Rotmensch S, Rosenzweig B, How H, Chediak J. The role of von Willebrand factor in pre-eclampsia. Thromb Haemost 1991;66:525-528.
27. Brenner B, Zwang E, Bronshtein M, Seligsohn U. von Willebrand factor multimer patterns in pregnancy-induced hypertension. Thromb Haemost 1989;62:715-717. (Pubitemid 19267424)
28. Pinsky DJ, Naka Y, Liao H, Oz MC, Wagner DD, Mayadas TN, Johnson RC, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest 1996;97:493-500.
29. Trampont P, Roudier M, Andrea AM, Nomal N, Mignot TM, Leborgne-Samuel Y, Ravion S, et al. The placental-umbilical unit in sickle cell disease pregnancy: a model for studying in vivo functional adjustments to hypoxia in humans. Hum Pathol 2004;35:1353-1359. (Pubitemid 39601575)
30. Parra-Cordero M, Bosco C, González J, Gutiérrez R, Barja P, Rodrigo R. Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta. J Mol Histol 2011;42:459-465.
31. Yeh IT, Kurman RJ. Functional and morphologic expressions of trophoblast. Lab Invest 1989;61:1-4. (Pubitemid 19203847)
32. Lanir N, Aharon A, Brenner B. Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost 2003;29:175-184.
33. Bosco C, Parra M, Barja P, Rodrigo R, Fernández V, Suarez M, Muñoz H. Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE). Histol Histopathol 2005;20:1045-1055. (Pubitemid 41489148)
34. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001;23:291-299. (Pubitemid 32762920)
35. Rodrigo R, Rivera G, Orellana M, Araya J, Bosco C. Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Life Sci 2002;71:2881-2895.
36. Pierleoni C, Castellucci M, Kaufmann P, Lund LR, Schnack Nielsen B. Urokinase receptor is up-regulated in endothelial cells and macrophages associated with fibrinoid deposits in the human placenta. Placenta 2003;24:677-685. (Pubitemid 37184789)
37. Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011;117:1071-1080.
38. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 1996;28:488-493. (Pubitemid 26296056)
39. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004;122:369-382. (Pubitemid 39506594)
40. Lee VM, Quinn PA, Jennings SC, Ng LL. NADPH oxidase activity in preeclampsia with immortalized lymphoblasts used as models. Hypertension 2003;41:925-931. (Pubitemid 36418467)
41. Tsukimori K, Yoshitomi T, Morokuma S, Fukushima K, Wake N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens 2008;21:1343-1346.
42. Gupta S, Aziz N, Sekhon L, Agarwal R, Mansour G, Li J, Agarwal A. Lipid peroxidation and antioxidant status in preeclampsia: a systematic review. Obstet Gynecol Surv 2009;64:750-759.
43. Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, Croft K, Beilin L. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension 2001;38:803-808. (Pubitemid 34258674)
44. Haack-Sorensen M, Friis T, Sindslev L, Mortensen S, Johnsen HE, Kastrup J. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cells therapy. Scand J Clin Lab Invest 2007;12;1-17
45. Lee MY, Huang JP, Chen YY, Aplin JD, Wu YH, Chen CY, Chen PC, Chen C P. Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1. PLoS ONE 2009; 4: 6913-6916.
46. Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalioglu E. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med 2010;23:880-886.
47. Orrico C, Pasquinelli G, Foroni L, Muscarà D, Tazzari PL, Ricci F, Buzzi M, et al. Dysfunctional vasa vasorum in diabetic peripheral artery obstructive disease with critical lower limb ischaemia. Eur J Vasc Endovasc Surg 2010;40:365-374.
48. Galazios G, Papazoglou D, Tsikouras P, Kolios G. Vascular endothelial growth factor gene polymorphisms and pregnancy. J Matern Fetal Neonatal Med 2009;22:371-378.
49. Myatt L. Control of vascular resistance in the human placenta. Placenta 1992;13:329-341.
50. Sebire NJ, Talbert DG. The dynamic placenta: a closer look at the pathophysiology of placental hemodynamics in uteroplacental compromise. Ultrasound Obstet Gynecol 2001;18:357-361.
51. Feller AC, Schneider H, Schmidt D, Parwaresch MR. Myofibroblast as a major cellular constituent of villous stroma in human placenta. Placenta 1985;6:405-415. (Pubitemid 16230461)
52. Michel JB. Role of endothelial nitric oxide in the regulation of the vasomotor system. Pathol Biol 1998;46:181-189. (Pubitemid 28160663)
53. Graf R, Langer JU, Schönfelder G, Oney T, Hartel-Schenk S, Reutter W, Schmidt HH. The extravascular contractile system in the human placenta. Morphological and immunocytochemical investigations. Anat Embryol 1994;190:541-548. (Pubitemid 24359593)
54. El-Remessy AB, Al-Shabrawey M, Platt DH, Bartoli M, Behzadian MA, Ghaly N, Tsai N, et al. Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J 2007;21:2528-2539. (Pubitemid 47230682)
55. Santos S, Peinado VI, Ramirez J, Morales-Blanhir J, Bastos R, Roca J, Rodriguez-Roisin R, Barbera JA. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1250-1256. (Pubitemid 36555098)
56. Webster R P, Roberts VH, Myatt L. Protein nitration in placenta-functional significance. Placenta 2008;29:985-994.
57. Bowen RS, Moodley J, Dutton MF, Theron AJ. Oxidative stress in pre-eclampsia. Acta Obstet Gynecol Scand 2001;80:719-725. (Pubitemid 32802548)
58. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002;100:4033-4039. (Pubitemid 35396870)
59. Joyce JM, Phernetton TM, Magness RR. Effect of uterine blood flow occlusion on shear stress-mediated nitric oxide production and endothelial nitric oxide synthase expression during ovine pregnancy. Biol Reprod 2002;67:320-326. (Pubitemid 34680671)
60. Lancellotti S, De Filippis V, Pozzi N, Peyvandi F, Palla R, Rocca B, Rutella S, et al. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress. Free Radic Biol Med 2010;48:446-456.
61. Kanfer A, Bruch JF, Nguyen G, He CJ, Delarue F, Flahault A, Nessmann C, Uzan S. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest 1996;74:253-258. (Pubitemid 26041027)
62. Kuo MC, Patschan D, Patschan S, Cohen-Gould L, Park HC, Ni J, Addabbo F, Goligorsky MS. Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells. J Am Soc Nephrol 2008;19:2321-2330.
63. Han SY, Jun JK, Lee CH, Park JS, Syn HC. Angiopoietin-2: a promising indicator for the occurrence of severe preeclampsia. Hypertens Pregnancy 2012;31:189-199.
64. Charnock-Jones DS. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature. J Anat 2002;200:607-615. (Pubitemid 34823052)